Answers are grounded in this paper and cite their sources.
The importance of glycemic control in preventing the chronic and devastating complications of diabetes is well established. Insulin administration is an important therapeutic option for managing diabetes, particularly for patients with profound insulin deficiency. Many insulin formulations are on the market, including short-acting insulin analogues, inhaled insulin, concentrated insulin, and basal insulin. Each category has a unique onset, peak, and duration of action. This article reviews the differing pharmacokinetic and pharmacodynamic properties and safety and efficacy data, and discusses the implications for clinical practice.
No takes yet. Share an insight, caveat, or question.
Luigi Meneghini (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: